Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

Trending 4 months ago

The first pill type of nan blockbuster GLP-1 weight nonaccomplishment narcotics has been launched successful nan US by Novo Nordisk astatine a little costs than jab varieties, accelerating a value warfare successful nan sector.

The Danish pharmaceutical institution said connected Monday that its once-a-day Wegovy pill, which received support from nan US regulator conscionable earlier Christmas, was now disposable successful nan country.

It launched nan supplier – nan first and only pill connected nan marketplace that imitates nan GLP-1 hormone to trim appetite – astatine importantly little prices than injectable versions.

Novo, which is known for its deed Wegovy and Ozempic injections for obesity and glucosuria respectively, said nan motorboat “opens caller possibilities for nan much than 100 cardinal Americans surviving pinch obesity”.

Self-paying patients tin bargain nan pill for $5 (£3.70) a day, aliases $149 a month, for nan starting dose of 1.5mg. Apart from being much affordable, nan caller type is expected to person wider entreaty by being needle free and easier for nan diligent to fresh into their routine.

The 4mg dose will besides beryllium disposable for $149 a period until 15 April, past $199, while nan highest doses costs $299 a month. Patients pinch security salary from $25 a month.

Matt Weston, a pharmaceutical expert astatine UBS, said nan value was little than expected. US database prices for weight-loss jabs are astir $1,000 a period aliases more, though Novo Nordisk started trading its Wegovy injection astatine $349 a period to rate payers successful November.

Novo Nordisk’s stock value roseate by much than 4% connected Monday connected news of nan launch, but is still down by 44% complete nan past twelvemonth amid fierce title from US rival Eli Lilly’s jabs Mounjaro and Zepbound.

The Danish company, erstwhile nan astir valuable successful Europe, hopes nan pill will thief it claw backmost marketplace stock aft it issued respective profit warnings, cut thousands of jobs and appointed caller guidance past year.

Both Novo and Eli Lilly person reduced prices of their jabs for group buying them for cash, alternatively than utilizing wellness insurance.

The Wegovy pill has only been approved successful nan US truthful far. The starting dose is now disposable astatine much than 70,000 US pharmacies specified arsenic CVS and Costco, arsenic good arsenic immoderate telehealth providers including Ro, LifeMD and Weight Watchers. The higher doses will go disposable later this week.

Eli Lilly is working connected its ain anti-obesity pill and, if approved, had planned to headdress higher doses astatine $399 a period for cash-paying patients.

Cash-paying patients will besides beryllium capable to bargain nan starting dose of nan pill for $149 a period connected Donald Trump’s direct-to-consumer website TrumpRx.

“We cognize location are group who are willing successful addressing their weight but person been waiting connected nan sidelines for a medicine that was correct for them,” said Ed Cinca, nan elder vice-president of trading and diligent solutions astatine Novo Nordisk.

“For galore of them, that hold is complete arsenic we tin now connection nan powerful efficacy of Wegovy successful a once-daily pill that demonstrated astir 17% weight loss, if each patients stayed connected treatment.”

The UK’s medicines regulator is reviewing nan company’s exertion for its Wegovy pill and is expected to make a determination connected whether to o.k. it earlier nan extremity of nan year.

More
Source theguardian.com
theguardian.com